CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-22 | NELSEN ROBERT Director | Other acquisition | +29,153 | 112,978 | ||
| 2021-11-22 | ARCH Venture Partners IX, LLC 10% owner | Other disposition | −217,781 | 9,219,394 | ||
| 2021-11-22 | ARCH Venture Partners IX, LLC 10% owner | Other disposition | −282,219 | 11,947,269 | ||
| 2021-11-22 | ARCH Venture Partners IX, LLC 10% owner | Other acquisition | +13,057 | 57,298 | ||
| 2021-11-22 | ARCH Venture Partners IX, LLC 10% owner | Other acquisition | +4,428 | 18,657 | ||
| 2021-11-17 | Pang Phillip Chief Medical Officer | Option exercise | +5,000 | $5.18 | $26K | 105,277 |
| 2021-11-17 | Pang Phillip Chief Medical Officer | Sale | −4,535 | $35.75 | $162K | 100,742 |
| 2021-11-17 | Pang Phillip Chief Medical Officer | Sale | −465 | $36.80 | $17K | 100,277 |
| 2021-11-17 | Pang Phillip Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 42,129 | ||
| 2021-11-16 | Virgin Herbert EVP, Research & CSO | Option exercise | +1,375 | $1.53 | $2K | 109,075 |
| 2021-11-16 | Virgin Herbert EVP, Research & CSO | Sale | −1,375 | $32.67 | $45K | 107,700 |
| 2021-11-16 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −1,375 | 245,630 | ||
| 2021-11-03 | Pang Phillip Chief Medical Officer | Option exercise | +5,000 | $5.18 | $26K | 105,277 |
| 2021-11-03 | Pang Phillip Chief Medical Officer | Sale | −5,000 | $36.47 | $182K | 100,277 |
| 2021-11-03 | Pang Phillip Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 47,129 | ||
| 2021-11-02 | Virgin Herbert EVP, Research & CSO | Option exercise | +1,375 | $1.53 | $2K | 109,075 |
| 2021-11-02 | Virgin Herbert EVP, Research & CSO | Sale | −1,375 | $36.94 | $51K | 107,700 |
| 2021-11-02 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −1,375 | 247,005 | ||
| 2021-10-20 | Pang Phillip Chief Medical Officer | Sale | −4,000 | $39.65 | $159K | 100,277 |
| 2021-10-19 | Virgin Herbert EVP, Research & CSO | Option exercise | +1,375 | $1.53 | $2K | 109,075 |
Page 34 of 54 · 1,063 trades